Literature DB >> 14754763

The evolution of airway function in early childhood following clinical diagnosis of cystic fibrosis.

Sarath C Ranganathan1, Janet Stocks, Carol Dezateux, Andrew Bush, Angie Wade, Siobhán Carr, Rosemary Castle, Robert Dinwiddie, Ah-Fong Hoo, Sooky Lum, John Price, John Stroobant, Colin Wallis.   

Abstract

This study aimed to investigate the evolution of airway function in infants newly diagnosed with cystic fibrosis (CF). FEV(0.5) was measured soon after diagnosis (median age of 28 weeks) and 6 months later in subjects with CF and on two occasions 6 months apart (median ages of 7.4 and 33.7 weeks) in healthy infants, using the raised-volume technique. Repeated measurements were successful in 34 CF and 32 healthy subjects. After adjustment for age, length, sex, and exposure to maternal smoking, mean FEV(0.5) was significantly lower in infants with CF both shortly after diagnosis and at the second test, with no significant difference in rate of increase in FEV(0.5) with growth between the two groups. When compared with published reference data, FEV(0.5) was reduced by an average of two z scores on both test occasions in those with CF, with 72% of individuals having an FEV(0.5) of less than 1.64 z-scores (i.e., less than the fifth percentile) on one or both test occasions. On longitudinal analysis, subjects with CF experienced a mean (95% confidence interval) reduction in FEV(0.5) of 20% (11, 28). Airway function is diminished soon after diagnosis in infants with CF and does not catch up during infancy and early childhood. These findings have important implications for early interventions in CF.

Entities:  

Mesh:

Year:  2004        PMID: 14754763     DOI: 10.1164/rccm.200309-1344OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  24 in total

1.  Is limited computed tomography the future for imaging the lungs of children with cystic fibrosis?

Authors:  S C Langton Hewer
Journal:  Arch Dis Child       Date:  2006-05       Impact factor: 3.791

2.  Infant pulmonary function testing: overview of technology and practical considerations--new current procedural terminology codes effective 2010.

Authors:  Burton L Lesnick; Stephanie D Davis
Journal:  Chest       Date:  2011-05       Impact factor: 9.410

3.  Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints.

Authors:  Stephanie D Davis; Margaret Rosenfeld; Gwendolyn S Kerby; Lyndia Brumback; Margaret H Kloster; James D Acton; Andrew A Colin; Carol K Conrad; Meeghan A Hart; Peter W Hiatt; Peter J Mogayzel; Robin C Johnson; Stephanie L Wilcox; Robert G Castile
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

4.  Growth and lung function in Asian patients with cystic fibrosis.

Authors:  B D Callaghan; A F Hoo; R Dinwiddie; I M Balfour-Lynn; S B Carr
Journal:  Arch Dis Child       Date:  2005-10       Impact factor: 3.791

5.  Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.

Authors:  Margaret Rosenfeld; Felix Ratjen; Lyndia Brumback; Stephen Daniel; Ron Rowbotham; Sharon McNamara; Robin Johnson; Richard Kronmal; Stephanie D Davis
Journal:  JAMA       Date:  2012-06-06       Impact factor: 56.272

6.  Inhaled hypertonic saline in infants and toddlers with cystic fibrosis: short-term tolerability, adherence, and safety.

Authors:  Margaret Rosenfeld; Stephanie Davis; Lyndia Brumback; Stephen Daniel; Ron Rowbotham; Robin Johnson; Sharon McNamara; Renee Jensen; Carol Barlow; Felix Ratjen
Journal:  Pediatr Pulmonol       Date:  2011-03-01

7.  Identification of SNPs in the cystic fibrosis interactome influencing pulmonary progression in cystic fibrosis.

Authors:  Franziska M Gisler; Thomas von Kanel; Richard Kraemer; André Schaller; Sabina Gallati
Journal:  Eur J Hum Genet       Date:  2012-08-15       Impact factor: 4.246

8.  Long-term gas exchange characteristics as markers of deterioration in patients with cystic fibrosis.

Authors:  Richard Kraemer; Philipp Latzin; Isabelle Pramana; Pietro Ballinari; Sabina Gallati; Urs Frey
Journal:  Respir Res       Date:  2009-11-12

Review 9.  Cystic fibrosis.

Authors:  Felix Ratjen; Scott C Bell; Steven M Rowe; Christopher H Goss; Alexandra L Quittner; Andrew Bush
Journal:  Nat Rev Dis Primers       Date:  2015-05-14       Impact factor: 52.329

Review 10.  Endpoints for clinical trials in young children with cystic fibrosis.

Authors:  Stephanie D Davis; Alan S Brody; Mary J Emond; Lyndia C Brumback; Margaret Rosenfeld
Journal:  Proc Am Thorac Soc       Date:  2007-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.